Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000809812 | SCV000949989 | uncertain significance | Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3 | 2018-12-14 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs752773971, ExAC 0.01%). This sequence change affects codon 159 of the NCF4 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the NCF4 protein. This variant has not been reported in the literature in individuals with NCF4-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. |